Ignelzi Troy A. has filed 8 insider transactions across 2 companies since May 2024.
Most recent transaction: a grant/award of 148000 shares of Rapport Therapeutics, Inc. ($RAPP) on February 02, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Rapport Therapeutics, Inc. | $RAPP | Ignelzi Troy A. | Chief Financial Officer | A | Stock Option (Right to Buy) | 148000 | $0.00 | 148,000.0000 | 47,661,138 | 9999.99% | 0.31% |
| June 26, 2025 | Contineum Therapeutics, Inc. | $CTNM | Ignelzi Troy A. | Director | A | Stock Option (right to buy) | 14750 | $0.00 | 14,750.0000 | 19,352,859 | 9999.99% | 0.08% |
| March 12, 2025 | Rapport Therapeutics, Inc. | $RAPP | Ignelzi Troy A. | Chief Financial Officer | P | Common Stock | 9900 | $10.10 | 9,900.0000 | 36,496,437 | 9999.99% | 0.03% |
| March 13, 2025 | Rapport Therapeutics, Inc. | $RAPP | Ignelzi Troy A. | Chief Financial Officer | P | Common Stock | 100 | $9.98 | 10,000.0000 | 36,496,437 | 1.01% | 0.00% |
| Feb. 3, 2025 | Rapport Therapeutics, Inc. | $RAPP | Ignelzi Troy A. | Chief Financial Officer | A | Stock Option (Right to Buy) | 142000 | $0.00 | 142,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Rapport Therapeutics, Inc. | $RAPP | Ignelzi Troy A. | Chief Financial Officer | A | Stock Option (Right to Buy) | 81366 | $0.00 | 81,366.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2024 | Contineum Therapeutics, Inc. | $CTNM | Ignelzi Troy A. | Director | A | Stock Option (right to buy) | 6350 | $0.00 | 6,350.0000 | 2,308,972 | 9999.99% | 0.28% |
| May 20, 2024 | Contineum Therapeutics, Inc. | $CTNM | Ignelzi Troy A. | Director | A | Stock Option (right to buy) | 23150 | $0.00 | 23,150.0000 | 2,308,972 | 9999.99% | 1.00% |